NSE · APOLLOHOSP
Apollo Hospitals Enter. Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹2,439 Cr with net profit ₹382 Cr — a 15.68% net margin, versus 16.22% the period before.
Shareholding
As of 2026-06-30
- Promoter28.02%
- Public6.77%
- FII41.5%
- DII23.72%
1,74,281 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.35× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Healthcare · ranked #1 of 79 by market cap · medians across 49 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Apollo Hospitals Enter. Limited(this company) | ₹1,28,522 Cr | 242.76 | 13.56 | 20.48% | 7.7% |
| Max Healthcare Institute Ltd. | ₹1,08,157 Cr | 315.71 | 10.06 | 13.42% | 17.23% |
| Fortis Healthcare Ltd. | ₹71,929 Cr | 270.67 | 7.27 | 10.53% | 11.41% |
| Narayana Hrudayalaya Ltd. | ₹42,540 Cr | 188.89 | 9.38 | 17.76% | 10.2% |
| Aster DM Healthcare Ltd. | ₹42,437 Cr | 301.12 | 9.27 | 8.48% | 8.36% |
| Global Health Limited | ₹38,558 Cr | 267.56 | 9.73 | 14.05% | 12.62% |
| Krishna Institute of Medical Sciences Ltd. | ₹31,827 Cr | 750.38 | 14.16 | 10.74% | 6.18% |
| Dr. Lal Path Labs Ltd. | ₹31,529 Cr | 239.29 | 12.57 | 20.13% | 18.27% |
| Poly Medicure Ltd. | ₹16,980 Cr | 256.15 | 5.47 | 10.37% | 17.18% |
| Dr. Agarwal's Health Care Limited | ₹15,558 Cr | 392.64 | 7.68 | 6.58% | 6.4% |
AI analysis
AI-generated · google/gemini-2.5-flashApollo Hospitals Enter. Limited is listed on the Indian markets with a market capitalization of Rs 126904 Cr. The company's PE ratio is 65.86 and it has an EPS of 104.67. The book value stands at 570.55. The company reported a revenue of Rs 21994.3 Cr.
Positives
- +Company revenue grew from Rs 2075.3 Cr in Mar 2025 to Rs 2438.5 Cr in Mar 2026.
- +The Return on Equity (ROE) is 19.9%, indicating efficiency in generating profits from shareholder equity.
- +The Return on Capital Employed (ROCE) is 17.27%, suggesting effective utilization of capital.
- +Promoter pledge level is 2.49%, which is relatively low.
- +The number of shareholders has increased from 38110 in Sep 2016 to 174281 in Jun 2026.
Negatives
- −Promoter holding has decreased from 28.02% in Jun 2026 to an earlier unspecified value in previous periods.
- −Significant pledges were reported historically, with 73.6% in Jun 2018, although current pledges are lower at 2.49%.
Financial performance
For the quarter ending Mar 2026, Apollo Hospitals Enter. Limited recorded a revenue of Rs 6605.5 Cr, with a net profit of Rs 529.3 Cr and an EBITDA of Rs 830.5 Cr. This follows a revenue of Rs 6477.4 Cr, net profit of Rs 502.3 Cr, and EBITDA of Rs 798.9 Cr in the Dec 2025 quarter. The annual revenue for Mar 2026 was Rs 2438.5 Cr, with a net profit of Rs 382.4 Cr and EBITDA of Rs 557.8 Cr.
Profitability & returns
The company achieved a Return on Equity (ROE) of 19.9%. The Return on Capital Employed (ROCE) was 17.27%. The most recent annual EPS reported is 104.67.
Balance sheet
Apollo Hospitals Enter. Limited has a debt-to-equity ratio of 0.61. The book value per share is Rs 570.55.
Ownership & pledges
As of Jun 2026, promoter holding in Apollo Hospitals Enter. Limited was 28.02%, while institutional investors held 65.21% (FII 41.50%, DII 23.72%). Public shareholding was 6.77%. Promoters have pledged 2.49% of their holding. The number of shareholders as of Jun 2026 was 174281.
Data as of — price: 2026-07-29 · financials: Mar 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.
Back to Apollo Hospitals Enter. Limitedshare price & fundamentals